Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer

Table 1 Patient characteristics of patients with and without clinical risk factors

Characteristics	Patients with risk factors (n = 82)	Patients without risk factor (n = 30)	P value
Mean age (yr)	51.8 ± 11.7	55.6 ± 8.3	0.06
Menopause, n (%)	39 (47.6)	17 (56.7)	0.52
Diagnosis, n (%)
Epithelial ovarian cancer	67 (81.7)	30 (100)	0.10
Fallopian tube cancer	4 (4.9	0
Peritoneal cancer	2 (2.4)	0
Synchronous ovarian and endometrial cancer	9 (11.0)	0
Histologic subtype, n (%)
High-grade serous	49 (59.8)	0	< 0.001
Low-grade serous	4 (4.9)	2 (6.7)
Endometrioid	15 (18.3)	13 (43.3)
Clear cell	12 (14.6)	12 (40.0)
Mixed endometrioid and clear cell	1 (1.2)	3 (10.0)
Adenocarcinoma	1 (1.2)	0
Stage, n (%)
1	27 (32.9)	13 (43.3)	0.06
2	10 (12.2)	8 (26.7)
3	38 (46.3)	9 (30.0)
4	7 (8.5)	0
Platinum sensitivity, n (%)	66 (80.5)	23 (76.7)	0.73
Germline mutation, n (%)	26 (31.7)	0	< 0.001